Press Releases

May 12, 2009 Conference Call
DUSA Pharmaceuticals Reports First Quarter 2009 Corporate Highlights and Financial Results Conference Call

May 11, 2009
DUSA INITIATES CLINICAL TRIAL OF LEVULAN® PDT ON HIGH-RISK SOLID ORGAN TRANSPLANT RECIPIENTS

May 6, 2009
DUSA Pharmaceuticals, Inc. Announces First Quarter Financial Results and Corporate Highlights Conference Call

May 5, 2009
DUSA Hits the Road with The Skin Cancer Foundation to Raise Awareness of Skin Cancer

March 11, 2009 Conference Call
Fourth Quarter and Full Year 2008 Corporate Highlights and Financial Results Conference Call

March 11, 2009
DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Corporate Highlights and Financial Results

March 6, 2009
DUSA PHARMACEUTICALS, INC.® TO HOST FOURTH QUARTER AND FULL YEAR 2008 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS CONFERENCE CALL

February 4, 2009
DUSA Pharmaceuticals, Inc. to Present at the 11th Annual Bio CEO & Investor Conference

January 29, 2009
DUSA ELECTS ALEXANDER CASDIN TO BOARD OF DIRECTORS

November 10, 2008
DUSA Investor Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference